Proteasome response to interferon-γ is altered in senescent human fibroblasts

FEBS Letters

Volumn 580, Issue 16, 2006, Pages 3989-3994

  Stratford, Fiona L L ^a   Chondrogianni, Niki ^b   Trougakos, Ioannis P ^b   Gonos, Efstathios S ^b   Rivett, A Jennifer ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b INSTITUTE OF BIOLOGY   (Greece)

Author keywords

Human fibroblasts; Immunoproteasome; Interferon ; Proteasome expression; Replicative senescence

Indexed keywords

GAMMA INTERFERON; PROTEASOME; REGULATOR PROTEIN;

ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL DIVISION; CELL GROWTH; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVE SITE; ENZYME INDUCTION; ENZYME MECHANISM; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; PRIORITY JOURNAL; SENESCENCE;

CELL AGING; CELLS, CULTURED; FIBROBLASTS; HUMANS; INTERFERON TYPE II; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; PROTEIN TRANSPORT;

EID: 33745367509     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.06.029     Document Type: Article

References (35)

1. Hershko A. The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle. Cell Death Differ. 12 (2005) 1191-1197
2. Orlowski M., and Wilk S. Ubiquitin-independent proteolytic functions of the proteasome. Arch. Biochem. Biophys. 415 (2003) 1-5
3. Kloetzel P.M. Antigen processing by the proteasome. Nat. Rev. Mol. Cell. Biol. 2 (2001) 179-187
4. Goldberg A.L., Cascio P., Saric T., and Rock K.L. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol. Immunol. 39 (2002) 147-164
5. Brooks P., Murray R.Z., Mason G.G., Hendil K.B., and Rivett A.J. Association of immunoproteasomes with the endoplasmic reticulum. Biochem. J. 352 (2000) 611-615
6. Khan S., van den Broek M., Schwarz K., de Giuli R., Diener P.A., and Groettrup M. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J. Immunol. 167 (2001) 6859-6868
7. Yewdell J.W. Immunoproteasomes: regulating the regulator. Proc. Natl. Acad. Sci. USA 102 (2005) 9089-9090
8. Rechsteiner M., and Hill C.P. Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol. 15 (2005) 27-33
9. Campisi J. Senescent cells, tumor suppression, and organismal ageing: good citizens, bad neighbors. Cell 120 (2005) 513-522
10. Borden E.C. Interferons and cancer: where from here?. J. Interferon Cytokine Res. 25 (2005) 511-527
11. Iakova P., Wang G.L., Timchenko L., Michalak M., Pereira-Smith O.M., Smith J.R., and Timchenko N.A. Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate. EMBO J. 23 (2004) 406-417
12. Xin H., Pereira-Smith O.M., and Choubey D. Role of IFI 16 in cellular senescence of human fibroblasts. Oncogene 23 (2004) 6209-6217
13. Tarunina M., Alger L., Chu G., Munger K., Gudkov A., and Jat P.S. Functional genetic screen for genes involved in senescence. Mol. Cell. Biol. 24 (2004) 10792-10801
14. Chondrogianni N., and Gonos E. Proteasome dysfunction in mammalian ageing: steps and factors involved. Exp. Gerontol. 40 (2005) 931-938
15. Chondrogianni N., Stratford F.L., Trougakos I.P., Friguet B., Rivett A.J., and Gonos E.S. Central role of the proteasome in senescence and survival of human fibroblasts. J. Biol. Chem. 278 (2003) 28026-28037
16. Szweda P.A., Friguet B., and Szweda L.I. Proteolysis, free radicals, and ageing. Free Radic. Biol. Med. 33 (2002) 29-36
17. Brooks P., Fuertes G., Murray R.Z., Bose S., Knecht E., Rechsteiner M.C., Hendil K.B., Tanaka K., Dyson J., and Rivett J. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem. J. 346 (2000) 155-161
18. Rivett A.J., Bose S., Pemberton A.J., Brooks P., Onion D., Shirley D., Stratford F.L., and Forti K. Assays of proteasome activity in relation to aging. Exp. Gerontol. 37 (2002) 1217-1222
19. Combaret L., Taillandier D., Dardevet D., Bechet D., Ralliere C., Claustre A., Grizard J., and Attaix D. Glucocorticoids regulate mRNA levels for subunits of the 19S regulatory complex of the 26S proteasome in fast-twitch skeletal muscles. Biochem. J. 378 (2004) 239-246
20. Chondrogianni N., Tzavelas C., Pemberton A.J., Nezis I.P., Rivett A.J., and Gonos E.S. Overexpression of proteasome beta5 assembled subunit increases the amount of proteasome and confers ameliorated response to oxidative stress and higher survival rates. J. Biol. Chem. 280 (2005) 11840-11850
21. Meiners S., Heyken D., Weller A., Ludwig A., Stangl K., Kloetzel P.M., and Kruger E. Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes. J. Biol. Chem. 278 (2003) 21517-21525
22. White L.C., Wright K.L., Felix N.J., Ruffner H., Reis L.F., Pine R., and Ting J.P. Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice. Immunity 5 (1996) 365-376
23. Foss G.S., and Prydz H. Interferon regulatory factor 1 mediates the interferon-gamma induction of the human immunoproteasome subunit multicatalytic endopeptidase complex-like 1. J. Biol. Chem. 274 (1999) 35196-35202
24. Namiki S., Nakamura T., Oshima S., Yamazaki M., Sekine Y., Tsuchiya K., Okamoto R., Kanai T., and Watanabe M. IRF-1 mediates upregulation of LMP7 by IFN-gamma and concerted expression of immunosubunits of the proteasome. FEBS Lett. 579 (2005) 2781-2787
25. Macagno A., Kuehn L., de Giuli R., and Groettrup M. Pronounced up-regulation of the PA28alpha/beta proteasome regulator but little increase in the steady-state content of immunoproteasome during dendritic cell maturation. Eur. J. Immunol. 31 (2001) 3271-3280
26. Fuertes G., Martin De Llano J.J., Villarroya A., Rivett A.J., and Knecht E. Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confluent conditions. Biochem. J. 375 (2003) 75-86
27. Cristofalo V.J., Lorenzini A., Allen R.G., Torres C., and Tresini M. Replicative senescence: a critical review. Mech. Ageing Dev. 125 (2004) 827-848
28. Shiraha H., Gupta K., Drabik K., and Wells A. Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors. J. Biol. Chem. 275 (2000) 19343-19351
29. Steinkamp M., and Schachtschabel D.O. Energetic stress in combination with tumor necrosis factor-alpha (TNF-alpha) induces apoptosis of human fibroblasts (WI-38) in vitro: reduced responsiveness of senescent cells. Z. Gerontol. Geriatr. 34 (2001) 437-440
30. Aggrawal B.B., Totpal K., LaPushin R., Chaturvedi M.M., Pereira-Smith O.M., and Smith J.R. Diminished responsiveness of senescent normal human fibroblasts to TNF-dependent proliferation and interleukin production in not due to its effect on the receptors or on the activation of a nuclear factor NF-kappa B. Exp. Cell Res. 218 (1995) 381-388
31. Heink S., Ludwig D., Kloetzel P.M., and Kruger E. IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc. Natl. Acad. Sci. USA 102 (2005) 9241-9246
32. Begley G.S., Horvath A.R., Taylor J.C., and Higgins C.F. Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome. Mol. Immunol. 42 (2005) 137-141
33. Rivett A.J., and Gardner R.C. Proteasome inhibitors: from in vitro uses to clinical trials. J. Pept. Sci. 6 (2000) 478-488
34. Adams J. Potential for proteasome inhibition in the treatment of cancer. Drug Discov. Today 8 (2003) 307-315
35. Mishto M., Santoro A., Bellavista E., Bonafe M., Monti D., and Franceschi C. Immunoproteasomes and immunosenescence. Ageing Res. Rev. 2 (2003) 419-432